S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   427.09 (+0.29%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.37 (+0.80%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   113.58 (-2.36%)
GE   156.74 (+0.69%)
CGC   7.75 (+19.41%)
DIS   113.58 (+0.57%)
AMC   2.92 (-2.01%)
PFE   25.35 (-0.28%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   427.09 (+0.29%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.37 (+0.80%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   113.58 (-2.36%)
GE   156.74 (+0.69%)
CGC   7.75 (+19.41%)
DIS   113.58 (+0.57%)
AMC   2.92 (-2.01%)
PFE   25.35 (-0.28%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   427.09 (+0.29%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.37 (+0.80%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   113.58 (-2.36%)
GE   156.74 (+0.69%)
CGC   7.75 (+19.41%)
DIS   113.58 (+0.57%)
AMC   2.92 (-2.01%)
PFE   25.35 (-0.28%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
S&P 500   5,041.43 (+0.38%)
DOW   37,950.27 (+0.52%)
QQQ   427.09 (+0.29%)
AAPL   167.83 (-0.10%)
MSFT   411.29 (-0.13%)
META   508.29 (+2.86%)
GOOGL   155.94 (+0.30%)
AMZN   181.82 (+0.30%)
TSLA   150.07 (-3.46%)
NVDA   857.38 (+2.03%)
AMD   156.31 (+1.49%)
NIO   4.05 (+3.58%)
BABA   69.37 (+0.80%)
T   16.21 (+0.56%)
F   12.11 (+0.58%)
MU   113.58 (-2.36%)
GE   156.74 (+0.69%)
CGC   7.75 (+19.41%)
DIS   113.58 (+0.57%)
AMC   2.92 (-2.01%)
PFE   25.35 (-0.28%)
PYPL   62.74 (-0.82%)
XOM   118.79 (+0.13%)
Free Trial

Protara Therapeutics (TARA) Insider Trading & Ownership

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)
Free TARA Stock Alerts
$2.70
-0.03 (-1.10%)
(As of 12:08 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Protara Therapeutics (NASDAQ:TARA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
18.40%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$888,152.40
Number Of
Insiders Selling
(Last 3 Years)
0
Get TARA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TARA Insider Buying and Selling by Quarter

Ad TradeSmith
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
Click here to learn more while there’s still time.

Protara Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2022Opaleye Management Inc.Major ShareholderBuy16,600$3.98$66,068.00  
8/11/2022Jesse SheffermanCEOBuy9,065$3.84$34,809.60  
6/30/2022Luke M BesharDirectorBuy10,000$3.10$31,000.00  
4/7/2022Opaleye Management Inc.Major ShareholderBuy2,345$4.74$11,115.30  
3/14/2022Luke M BesharDirectorBuy10,000$4.25$42,500.00  
3/10/2022Luke M BesharDirectorBuy10,000$4.46$44,600.00  
1/28/2022Opaleye Management Inc.Major ShareholderBuy24,031$4.96$119,193.76  
12/29/2021Opaleye Management Inc.Major ShareholderBuy4,500$6.98$31,410.00  
12/27/2021Opaleye Management Inc.Major ShareholderBuy36,700$6.53$239,651.00  
12/23/2021Opaleye Management Inc.Major ShareholderBuy1,300$6.60$8,580.00  
12/20/2021Opaleye Management Inc.Major ShareholderBuy703$6.49$4,562.47  
12/16/2021Opaleye Management Inc.Major ShareholderBuy7,563$6.41$48,478.83  
11/17/2021Opaleye Management Inc.Major ShareholderBuy9,118$6.98$63,643.64  
11/4/2021Opaleye Management Inc.Major ShareholderBuy6,557$6.50$42,620.50  
6/10/2021Martin Sebastian OlivoInsiderBuy9,893$10.10$99,919.30  
(Data available from 1/1/2013 forward)

TARA Insider Trading Activity - Frequently Asked Questions

Who is on Protara Therapeutics's Insider Roster?

The list of insiders at Protara Therapeutics includes Jesse Shefferman, Luke M Beshar, Martin Sebastian Olivo, and Opaleye Management Inc.. Learn more on insiders at TARA.

What percentage of Protara Therapeutics stock is owned by insiders?

18.40% of Protara Therapeutics stock is owned by insiders. Learn more on TARA's insider holdings.

Which Protara Therapeutics insiders have been buying company stock?

The following insiders have purchased TARA shares in the last 24 months: Jesse Shefferman ($34,809.60), Luke M Beshar ($31,000.00), and Opaleye Management Inc. ($66,068.00).

How much insider buying is happening at Protara Therapeutics?

Insiders have purchased a total of 35,665 TARA shares in the last 24 months for a total of $131,877.60 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:TARA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
He Is Giving Away Bitcoin
Crypto Swap Profits
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Paradigm Press
Your Money is Not Safe
American Alternative